Literature DB >> 20378513

Cryoablation versus radiofrequency ablation for atrioventricular nodal reentrant tachycardia in children: long-term results.

John Papagiannis1, Kyriaki Papadopoulou, Spyridon Rammos, Demosthenes Katritsis.   

Abstract

INTRODUCTION: Cryoablation is used increasingly for the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). We sought to compare the long-term outcomes of cryoablation (Cryo) vs. radiofrequency (RF) ablation for the treatment of AVNRT in children.
METHODS: Two groups of consecutive patients were analyzed retrospectively: the RF group, 20 patients (60% males, mean age 13.25 +/- 2.59 years), and the Cryo group, 20 patients (55% males, mean age 12.17 +/- 3.07 years). Follow up was 52.7 +/- 16.5 months for the RF and 32.8 +/- 11.9 months for the Cryo group.
RESULTS: Acute success rates (100% for RF vs. 90% for Cryo), procedural times (147.75 +/- 37.15 min for RF vs. 184.4 +/- 75.59 min for Cryo), and fluoroscopy times (10.9 +/- 6.46 min for RF vs. 6.41 +/- 6.92 min for Cryo) were not statistically significantly different between the two groups. The number of lesions was significantly higher in RF than in Cryo (8.85 +/- 6.63 vs. 3.6 +/- 1.9, p=0.007). Transient AV block during ablation occurred in 1 patient in each group. No permanent AV block was observed. Recurrence rate was 10% in the RF and 27.7% in the Cryo group (p=0.222) occurring up to 14 months after the procedure.
CONCLUSIONS: Cryoablation is safe and effective for the treatment of AVNRT in pediatric patients, but there is a tendency for higher recurrence rates compared to radiofrequency ablation. Techniques to reduce recurrence rates after cryoablation are needed.

Entities:  

Mesh:

Year:  2010        PMID: 20378513

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  7 in total

1.  Transitioning from Radiofrequency Ablation to Cryoablation for Treatment of Pediatric Atrioventricular Nodal Reentrant Tachycardia: A Single Tertiary Center Experience.

Authors:  Serhat Koca; Vedat Kavurt; Ibrahim Ece; Ozcan Ozeke; Firat Ozcan; Serkan Cay; Serkan Topaloglu; Dursun Aras
Journal:  Pediatr Cardiol       Date:  2022-03-31       Impact factor: 1.838

Review 2.  Cryoablation versus radiofrequency ablation of atrioventricular nodal reentrant tachycardia.

Authors:  Pasquale Santangeli; Riccardo Proietti; Luigi Di Biase; Rong Bai; Andrea Natale
Journal:  J Interv Card Electrophysiol       Date:  2013-11-29       Impact factor: 1.900

3.  Value of an old school approach: safety and long-term success of radiofrequency current catheter ablation of atrioventricular nodal reentrant tachycardia in children and young adolescents.

Authors:  Henrike Siebels; Christian Sohns; Jan-Hendrik Nürnberg; Jürgen Siebels; Klaus Langes; Joachim Hebe
Journal:  J Interv Card Electrophysiol       Date:  2018-05-15       Impact factor: 1.900

4.  Transcatheter Cryoablation Procedures without Fluoroscopy in Pediatric Patients with Atrioventricular Nodal Reentrant Tachycardia: A Single-Center Experience.

Authors:  Sevket Balli; Mehmet Kucuk; Mustafa Orhan Bulut; Ilker Kemal Yucel; Ahmet Celebi
Journal:  Acta Cardiol Sin       Date:  2018-07       Impact factor: 2.672

5.  Pulmonary Thromboembolism Following Radio-Frequency Ablation of the Atrioventricular Node in a Patient Heterozygous for the Factor V Leiden and the Mthfr C677T Mutations.

Authors:  Dp Pešut; Sv Raljević; Mdj Kontić; Dz Božić; Ib Buha; Rs Stević
Journal:  Balkan J Med Genet       Date:  2011-06       Impact factor: 0.519

6.  Remote magnetic navigation shows superior long-term outcomes in pediatric atrioventricular (nodal) tachycardia ablation compared to manual radiofrequency and cryoablation.

Authors:  Anna M E Noten; Janneke A E Kammeraad; Nawin L Ramdat Misier; Sip Wijchers; Ingrid M van Beynum; Michiel Dalinghaus; Thomas B Krasemann; Sing-Chien Yap; Natasja M S de Groot; Tamas Szili-Torok
Journal:  Int J Cardiol Heart Vasc       Date:  2021-10-01

7.  Interventional electrophysiology in children: a single-center experience.

Authors:  Pasha Mosaed; Mohammad Dalili; Zahra Emkanjoo
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.